Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of First Line Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma

NCT01590160 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT01590160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01590160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of First Line Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma
Lead sponsor
University College, London
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2013
Completion date
November 5, 2019
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer - malignant pleural mesothelioma